Most importantly, they are comparing two very strange data sets from different times and trials. It is essentially meaningless as far as I can tell. More smoke and mirrors from NVCR, IMHO. But note this. It is another example of NVCR putting out old data in new ways seemingly in anticipation to offset expected data from NWBO, IMO . We saw this pattern reach its climax a couple years ago with what appeared to be a very manipulated/questionable retroactive data article on survival correlating with time of use (even Dr. Stupp would not sign onto that one), but a deep dive into the stats showed instead their never blinded trial separated patients who would likely live longer into those time of use cohorts in a very sophisticated manner. Brazen. To me, they are a marketing company. That’s it.